- Home
- BBIO vs GPN Comparison
BBIO vs GPN Comparison
Compare BBIO & GPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | GPN |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 18.7B |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BBIO | GPN |
|---|---|---|
| Price | $78.35 | $92.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 25 | 18 |
| Target Price | $86.33 | ★ $92.56 |
| AVG Volume (30 Days) | 2.1M | ★ 2.9M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $502,076,000.00 | ★ $3,975,163,000.00 |
| Revenue This Year | $89.45 | $63.81 |
| Revenue Next Year | $73.78 | $6.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.26 | 17.92 |
| 52 Week Low | $48.78 | $61.16 |
| 52 Week High | $93.42 | $95.88 |
Technical Indicators
Market Signals| Indicator | BBIO | GPN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 61.65 |
| Support Level | N/A | $66.88 |
| Resistance Level | N/A | $95.58 |
| Average True Range (ATR) | 0.00 | 2.62 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 0.00 | 71.70 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and historically focused on serving small and midsize merchants. The Worldpay acquisition pushes the company into the large merchant space and expands the company's international operations. Following the Worldpay acquisition, the company will process almost $4 trilliion in payment volume.